Novo Nordisk A/S (NONOF)
47.52
-0.58
(-1.22%)
USD |
OTCM |
Feb 20, 16:00
Novo Nordisk Market Cap : 211.29B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 952.34B |
| Hims & Hers Health, Inc. | 3.558B |
| Genmab A/S | 18.04B |
| Ascendis Pharma A/S | 13.81B |
Market Cap Related Metrics
| PE Ratio | 13.70 |
| PS Ratio | 4.525 |
| PEG Ratio | 2.426 |
| Price to Book Value | 6.925 |
| Price to Free Cash Flow | 46.84 |
| Price | 47.52 |
| Earnings Yield | 7.30% |
| PEGY Ratio | 1.475 |
| Operating PE Ratio | 10.99 |
| Normalized PE Ratio | 13.70 |